Neurosense Therapeutics Ltd. (NRSN) has released an update.
NeuroSense Therapeutics Ltd., an Israeli-based company, has announced the issuance and sale of ordinary shares through a Sales Agreement with JonesTrading Institutional Services LLC. The shares are to be offered pursuant to a registration statement and will be validly issued, fully paid, and non-assessable upon completion of certain corporate procedures. This move is part of the company’s efforts to increase its financial flexibility and continue its growth trajectory.
For further insights into NRSN stock, check out TipRanks’ Stock Analysis page.
